Aryabhatta Sadhu: Contributing to Nepal’s First CAR-T Cell Therapy Case
Aryabhatta Sadhu, Attending Consultant and Head of Transfusion Medicine at Fortis Hospital Shalimar Bagh, New Delhi, Member of AABB, Member International Society of Blood Transfusion (ISBT), shared Luca Gattinoni‘s post on LinkedIn:
“It feels incredibly rewarding to know that a seemingly simple act of helping a fellow consultant with a patient eventually connects you to a landmark moment in the country’s medical history.
I was involved in the patient selection and ensuring adequate T-cell collection for this patient, with the collected cells serving as the leukapheresis starting material (LSM) for CAR-T cell manufacturing.
Only later did I learn that this was the ‘first CAR-T cell therapy case in the country’.
Grateful to have played a small part in a milestone that represents so much progress in Nepal’s cellular therapy. Sometimes, you only realise the significance of your contribution in hindsight.”
Luca Gattinoni, Director of the Division of Functional Immune Cell Modulation at Leibniz Institute for Immunotherapy, shared a post on LinkedIn:
“Three years ago I traveled to Nepal for an international meeting to raise awareness of cellular therapies in the country. This month, Nepal has treated its first patient with CAR-T cells manufactured locally.
It has been a privilege to support this effort from the start. Congratulations to my former postdoc Sanjivan Gautam and CRM Nepal for turning that vision into reality in just three years, and to Dr. Anjan Shrestha and the team at Tribhuvan University Teaching Hospital.
Nepal can now be a model for other low- and middle-income countries seeking to bring CAR-T therapy to their patients.”
Find more posts featuring Aryabhatta Sadhu on Hemostasis Today.
-
Oct 29, 2026, 13:50Lainie Kazan’s Story and the Clinical Risks of Post-Injury Immobilization
-
Oct 29, 2026, 12:17Bridget King: IBM Employees Support Blood Donation Efforts
-
Oct 29, 2026, 12:08Georgina Pearson: A Promising Blood Donation Partnership With Missed Potential
-
Oct 29, 2026, 11:59Dianne E. van der Wal: Cryopreserved Platelets in Transfusion Medicine
-
Oct 29, 2026, 11:50Denis Oduor: Dengue-Associated Thrombocytopenia and the Risk of Bleeding
-
Oct 29, 2026, 11:42Akshat Jain: Thrombin Generation and Factor VIII Equivalence With Mim8
-
Oct 28, 2026, 23:39Paul Tortland: What a New PRP Study Really Tells Us About Knee Osteoarthritis
-
Oct 28, 2026, 23:34Jawad Derbas: Comparing Mechanical and Pharmacomechanical VTE Prophylaxis in Spine Surgery
-
Oct 28, 2026, 23:31Giulio Maria Pasinetti: Aspirin Use Linked to Lower Dementia Risk in Older Adults With Specific Genetic Characteristics